The naturally occurring phospholipids lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) have recently emerged as bioactive compounds that exert mitogenic effects in many cell types, including osteoblasts. In the current study, we examined the ability of each of these compounds to influence osteoblast survival. Using terminal deoxynucleotidyl transferase-mediated deoxyuridine 5-triphosphate nick-end labeling and DNA fragmentation assays, we found that both LPA and S1P dose-dependently inhibited (by at least 50% and 40%, respectively) the apoptosis induced by serum withdrawal in cultures of primary calvarial rat osteoblasts and SaOS-2 cells. The antiapoptotic effects were inhibited by pertussis toxin, wortmannin, and LY294002, implicating G i proteins and phosphatidylinositol-3 kinase (PI-3 kinase) in the signaling pathway that mediates phospholipid-induced osteoblast survival. Specific inhibitors of p42/44 MAPK signaling did not block LPA-or S1P-induced osteoblast survival. LPA and S1P induced PI-3 kinase-dependent activation of p70 S6 kinase, but rapamycin, a specific inhibitor of p70 S6 kinase activation, did not prevent phospholipid-induced osteoblast survival. LPA and S1P also inhibited apoptosis in Swiss 3T3 fibroblastic cells in a G i protein-dependent fashion. In fibroblastic cells, however, the antiapoptotic effects of S1P were sensitive to inhibition of both PI-3 kinase and p42/44 MAPK signaling, whereas those of LPA were partially abrogated by inhibitors of p42/44 MAPK signaling but not by PI-3 kinase inhibitors. These data demonstrate that LPA and S1P potently promote osteoblast survival in vitro, and that cell-type specificity exists in the antiapoptotic signaling pathways activated by phospholipids. (Endocrinology 143: 4755-4763, 2002) 
I
T IS CURRENTLY BELIEVED that up to 65% of osteoblasts undergo apoptosis during the bone remodeling cycle (1) . The majority of surviving osteoblasts become osteocytes, buried within the bone matrix, which probably play a role in coordinating further remodeling events, including repair of skeletal microdamage (2) . An increase in osteoblast and/or osteocyte apoptosis would therefore be expected to compromise skeletal integrity and may contribute to the pathogenesis of the bone loss and fragility fractures associated with sex hormone deficiency and glucocorticoid excess (3) (4) (5) (6) (7) . Conversely, interventions that suppress osteoblast apoptosis, such as intermittent administration of parathyroid hormone (8) , increase bone mass, and reduce skeletal fragility (9) . Thus, identifying the factors that regulate osteoblast survival and the molecular mechanisms by which such factors act is important to our understanding of bone remodeling in physiological and pathophysiological conditions.
In recent years, the naturally occurring phospholipids lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) have emerged as important bioactive compounds in their own right (10 -12) . LPA and S1P are present in the systemic circulation at high nanomolar to low micromolar concentrations and are synthesized and released by platelets, adipocytes, and fibroblasts in vitro (13) (14) (15) . Thus, each of these compounds appears to exert endocrine and paracrine actions, and a growing body of evidence suggests that S1P also has important intracrine effects (16, 17) . A family of specific G protein-coupled receptors (edg or lp) has been identified, members of which probably mediate some of the diverse cellular actions of LPA and S1P (18) . Thus, LPA and S1P have been reported to induce proliferation and cytoskeletal reorganization in several cell types (16, 19) , including osteoblasts (20 -22) . Recent evidence suggests that phospholipids also promote survival in macrophages (23) , Schwann cells (24) , T lymphocytes (25) , fibroblasts (26) , and endothelial cells (27) .
In the current paper, we report that LPA and S1P prevent apoptosis in osteoblastic cells, and that this effect is in each case sensitive to inhibitors of G i proteins and PI-3 kinase, but not of p42/44 MAPK signaling. Neither of the PI-3 kinase effectors protein kinase B (PKB)/Akt or p70 S6 kinase appears to be required for phospholipid-induced osteoblast survival. We also demonstrate cell-type specificity in the survival pathways activated by phospholipids because p42/44 MAPK activation appears to be important for the antiapoptotic effects of LPA and S1P in fibroblastic cells. 
Cell culture
Primary rat osteoblastic cells were prepared as previously described (28) . In brief, osteoblasts from collagenase digests three to four of 20-d fetal rat calvariae were pooled, centrifuged, and then washed in DMEM with 10% fetal calf serum (FCS), resuspended in DMEM/10% FCS, and placed in 75 cm 2 flasks. After 48 h, the medium was changed to MEM containing 10% FCS. Confluence of the primary cultures was reached within 5-6 d, at which time the cells were subcultured. Only cells passaged on one to two occasions were used in the experiments detailed below. The osteoblast-like character of these cells has been established by demonstration of alkaline phosphatase staining in more than 95% of cells, osteocalcin production, and a sensitive adenylyl cyclase response to PTH and prostaglandin E 2 (28) .
The human osteoblastic SaOS-2 cell line and the murine Swiss 3T3 fibroblastic cell line were grown in MEM containing 10% FCS and subcultured into six-well plates for assessment of apoptosis as described below.
Apoptosis assays
Terminal deoxynucleotidyl transferase-mediated deoxyuridine 5Ј-triphosphate nick end labeling (TUNEL) assay. Apoptosis in cultures of primary rat osteoblasts was assessed using the TUNEL method (DeadEnd, Promega Corp., Madison, WI), according to the manufacturer's instructions. Cells were seeded in eight-well chamber slides at 5 ϫ 10 4 cells/ml in MEM containing 5% FCS. Twenty-four hours later, the medium was changed to MEM/0.1%BSA and the cells incubated overnight. The following morning, test substances were added in fresh MEM/0.1% BSA for 18 h. At the end of the treatment period, cells were fixed in 2% paraformaldehyde for 15 min, then permeabilized with 1% Triton in PBS for 5 min. Thereafter, biotinylated nucleotides were added in the presence of terminal deoxynucleotidyl transferase for 1 h at 37 C, and the reaction terminated with 2ϫ SSC. Endogenous peroxidases were blocked with 0.3% H 2 O 2 for 5 min, streptavidin-horseradish peroxidase added for 30 min, and apoptotic nuclei colorized by addition of diaminobenzidine/ H 2 O 2 mixture. After counterstaining with hematoxylin, the number of apoptotic nuclei per microscopic field was counted and expressed as a proportion of that observed in the cells exposed to serum starvation alone throughout the entire treatment period. Each experiment was performed at least twice and involved assessment of at least six chambers per treatment condition.
DNA fragmentation. Apoptosis in cultures of primary rat osteoblasts, SaOS-2 cells and Swiss 3T3 cells was assessed in the presence and absence of signaling inhibitors using a DNA fragmentation assay (26, 29 -31) . Cells were seeded in six-well plates at 5 ϫ 10 4 /ml, grown to semiconfluence and labeled with 3 [H]-thymidine (0.5 Ci/well) for 4 h in MEM containing 5-10% FCS. Thereafter, the medium containing unincorporated [ 3 H]-thymidine was removed and the cells incubated in MEM/0.1%BSA with or without phospholipid and in the presence or absence of inhibitors for a further 24 h. Inhibitors were added 30 min before phospholipid. After extensive washing, cells were lysed in TE buffer (10 mm Tris-HCl; 1 mm EDTA, pH 7.4; 0.2% Triton X-100) and the lysates centrifuged at 13,000 rpm for 15 min. Radioactivity was measured in the supernatant and pellet by scintillation counting and the proportion of fragmented DNA, representing apoptotic cells, was calculated by the following formula: % apoptosis ϭ
pellet. Preliminary time-course experiments confirmed that there was a progressive increase in the radioactivity measured in the cell lysate supernatant during the period of serum starvation, confirming that the supernatant counts are derived from degradation of prelabeled DNA. Each experiment included triplicate measurements under each treatment condition. In each experiment involving the use of pharmacological inhibitors, an inhibitor-only treatment was performed to control for independent effects on cell survival of the inhibitor or its vehicle. Apoptosis as a percentage of control values was calculated by expressing the values obtained in cultures of cells exposed to phospholipid or phospholipid and inhibitor as a proportion of the values obtained in cultures of cells exposed to serum starvation or inhibitor alone, respectively.
Immunoblotting
Primary rat osteoblastic cells were grown to near-confluence in MEM 5% FCS in six-well plates, serum-starved in MEM 0.1% BSA overnight, and treated with phospholipids at the indicated concentrations for the periods of time indicated in the figure legends. Inhibitors were added 30 min before phospholipid. Whole-cell lysates were prepared by scraping the cells in ice-cold HNTG lysis buffer (50 mm HEPES, pH 7.5; 150 mm NaCl; 1% Triton; 10% glycerol; 1.5 mm MgCl 2 ; 1 mm EDTA) containing a cocktail of protease and phosphatase inhibitors (1 mm phenylmethylsulfonylfluoride, 1 g/ml pepstatin, 10 g/ml leupeptin, 10 g/ml aprotinin, 1 mm sodium vanadate, 500 mm NaF), and analyzed by immunoblotting as previously described (20) . Detection of proteins of interest was by enhanced chemiluminescence.
Statistical analyses
All data were analyzed using GraphPad Software, Inc. (San Diego, CA) Prism. Data from individual experiments were expressed as treatment to control ratios. Data from at least three separate experiments under each treatment condition were collated and analyzed by ANOVA to determine the effects of LPA and S1P on osteoblast survival, in the presence and absence of the indicated inhibitor. All data shown are mean Ϯ sem unless otherwise stated.
Results

LPA and S1P prevent apoptosis in osteoblastic cells
Both LPA (10 m) and S1P (10 m) decreased the apoptosis observed in response to serum deprivation in cultures of primary rat osteoblastic cells, as judged by number of TUNEL-positive cells (Fig. 1 ). This effect was dose dependent ( Fig. 2A ) and apparent at concentrations as low as 10 nm of LPA and 100 nm of S1P. The antiapoptotic effect of LPA and S1P in osteoblastic cells was confirmed in primary rat osteoblasts (Fig. 2B, left panel) and SaOS-2 cells (Fig. 2B , right panel) using a DNA fragmentation assay. In each in vitro assay, LPA (10 m) and S1P (5-10 m) reduced osteoblast apoptosis induced by serum withdrawal by at least 50% and 40%, respectively. In primary rat osteoblasts, the combination of 10 m LPA and 5 m S1P produced slightly greater reduction in apoptosis than either phospholipid alone (mean Ϯ sem % apoptosis; LPA ϩ S1P 27.0 Ϯ 1.5%, LPA 42.3 Ϯ 0.7%, S1P 35.7 Ϯ 2.3%). These data demonstrate that phospholipids are potent survival factors in osteoblastic cells.
Phospholipid-induced osteoblast survival requires G i proteins and PI-3 kinase, but not p42/44 MAPKs
Pretreatment of primary rat osteoblastic cells with the G i protein inhibitor pertussis toxin (10 ng/ml) completely reversed the antiapoptotic effect of both LPA and S1P (Fig. 3A) . In contrast, the pan-PKC inhibitor calphostin C had no effect on phospholipid-induced osteoblast survival (Fig. 3A) . Because signaling through PI-3 kinases has been implicated in the antiapoptotic effects of many growth factors (32), we examined the effect of the specific inhibitors of PI-3 kinase, LY294002 and wortmannin, on phospholipid-induced osteoblast survival. As shown in Fig. 3B , LY294002 dose dependently inhibited the antiapoptotic effect of each phospholipid. Wortmannin also inhibited LPA-and S1P-induced osteoblast survival. In contrast, neither of the specific inhibitors of p42/44 MAPK signaling, PD 98059 and U-0126, influenced osteoblast survival induced by either LPA or S1P (Fig. 3C ). These data demonstrate that G i proteins and PI-3 kinases, but not p42/44 MAPKs, are required for phospholipid-induced survival in osteoblastic cells.
Neither Akt/PKB nor p70 s6 kinase mediate phospholipidinduced PI-3 kinase-dependent survival in osteoblastic cells
Akt/PKB is considered to be an important downstream mediator of PI-3 kinase-dependent survival signaling (33) . We were unable to convincingly demonstrate activation of Akt (as judged by phosphorylation at the Ser 473 moiety) by either LPA or S1P in osteoblastic cells (Fig. 4, top panel) , although each phospholipid activated p42/44 MAPKs in the same experiments (Fig. 4, middle panel) . Similar results were obtained in 6 independent experiments. In contrast, low concentrations of FCS (Fig. 4, top panel, lanes 6 and 12) or IGF-1 (data not shown) did consistently induce phosphorylation of Akt in our cells, confirming that Akt phosphorylation is inducible in osteoblasts.
Among many other putative intracellular targets of PI-3 kinase activation is the ribosomal protein kinase p70 S6 kinase (34), activation of which is strongly PI-3 kinase-dependent (35) . Recent evidence has implicated this kinase in survival signaling (36) . As shown in Fig. 5A , top panel, both LPA and S1P induced phosphorylation of p70 S6 kinase in osteo- blastic cells at Thr 389 , a critical event for p70 S6 kinase activation. This effect was PI-3 kinase dependent because it was prevented by pretreatment with LY294002 (Fig. 5A , lanes 5 and 6). As expected, phospholipid-induced activation of p70 S6 kinase was also sensitive to rapamycin, a specific inhibitor of p70 S6 kinase activation (Fig. 5B, lanes 2 and 3) . We therefore tested the ability of rapamycin to block phospholipid-induced osteoblast survival. As is shown in Fig. 5C , rapamycin at concentrations of up to 50 ng/ml had no effect on the antiapoptotic actions of either phospholipid. Taken together, these data demonstrate activation of PI-3 kinase signaling in osteoblastic cells by LPA and S1P, but suggest that neither Akt/PKB nor p70 S6 kinase is the important downstream mediator of the PI-3 kinase-dependent antiapoptotic effects of LPA and S1P.
Survival signals activated by S1P and LPA differ between osteoblastic and fibroblastic cells
Recent evidence suggests that LPA promotes survival in fibroblastic cells independently of PI-3 kinase (26). We therefore compared the proximal signaling events required for phospholipid-induced survival in osteoblastic and fibroblastic cells. As shown in Fig. 6A , 5% FCS reduced apoptosis in Swiss 3T3 fibroblastic cells to a level 80% below that observed in cells exposed to serum starvation. LPA and S1P each prevented apoptosis induced by serum withdrawal in Swiss 3T3 fibroblastic cells, and the magnitude of the effect (50 -60% reduction) was comparable to that which we observed in osteoblastic cells (compare with Fig. 2B ). As was observed in osteoblastic cells, the antiapoptotic effect of each phospholipid in Swiss 3T3 cells was blocked by pertussis toxin (Fig. 6B) . In contrast to our findings in osteoblastic cells, however, there was evidence of ligand-specific survival signaling in fibroblastic cells. Thus, LPA-induced fibroblast survival was insensitive to either of the PI-3 kinase inhibitors LY294002 and wortmannin (Fig. 6C ), but partially inhibited by each of the p42/44 MAPK signaling inhibitors U-0126 and PD 98059 (Fig. 6D) , whereas S1P-induced fibroblast survival was blocked by inhibitors of both PI-3 kinase and p42/44 MAPK signaling (Fig. 6, C and D) . Taken together, these data demonstrate cell-type and ligand-type specificity in survival signaling initiated in response to LPA and S1P.
Discussion
There is a growing awareness of the importance of osteoblast apoptosis in skeletal homeostasis, and in the therapeutics of osteoporosis (1, 2) . The majority of osteoblastic cells are believed to suffer an apoptotic fate, and several hormones and cytokines that are known to regulate skeletal integrity do so in part by altering osteoblast and/or osteocyte survival (3) (4) (5) (6) (7) . Therefore, identifying compounds that influence osteoblast apoptosis, and characterizing the mechanism(s) by which they exert their effects, is likely to significantly advance our understanding of skeletal physiology and pathophysiology. The current paper demonstrates that the naturally occurring phospholipids LPA and S1P exert potent antiapoptotic effects on osteoblastic cells in vitro, at concentrations that are comparable to those reported in the systemic circulation (15, 37) . Taken together with recent evidence that each of these compounds is a potent osteoblast mitogen (20 -22) , the current data support the notion that LPA and S1P may be physiological regulators of bone metabolism.
Phospholipid signaling is a complex process. LPA and S1P activate intracellular signaling by binding to members of the recently characterized family of edg/lp G protein-coupled receptors, which currently includes eight members (38, 39) . Edg 1, 3, 5, 6 , and 8 are specific S1P receptors, whereas edg 2, 4, and 7 are specific LPA receptors. Several of these receptors are expressed in a variety of tissues, such that more than one receptor for either phospholipid may be expressed in the same tissue (36, 37) . In addition, there is substantial overlap between the phospholipid receptors in the intracellular sig- naling pathways activated following ligand binding (11, 40) . Further, some evidence suggests that some of the growth factor-like effects of LPA and S1P are not transduced through edg/lp receptors (41) . Our data demonstrate that the ability of LPA and S1P to prevent osteoblast apoptosis is dependent upon functional G i proteins and the phospholipid kinase PI-3 kinase. The former observation is consistent with a large body of evidence that attests to the role of G i proteins in mediating the proliferative and antiapoptotic effects of each compound in a variety of tissues (16, 42) . Thus, in osteoblasts G i proteins are now implicated in phospholipid-induced proliferation and survival (20) (current paper). The nearcomplete inhibition of the proliferative and antiapoptotic effects of both LPA and S1P in osteoblastic cells by pertussis toxin strongly suggests that specific G protein-coupled receptors transduce these effects. Receptors for both S1P and LPA are expressed in osteoblastic cells (43) (Hill, B. , and A. Grey, submitted), although which of these receptors mediate the mitogenic and/or antiapoptotic effects of these agents is currently unknown.
While G i proteins are important for both the mitogenic and antiapoptotic effects of LPA and S1P in osteoblastic cells, the role of PI-3 kinase appears to be restricted to survival signaling, since specific inhibitors of PI-3 kinase do not prevent the potent proliferative actions of LPA or S1P in osteoblastic cells (17) (Xu, X., and A. Grey, submitted). PI-3 kinase signaling is believed to play an important role in cell survival in a diverse range of tissues in response to a broad range of extracellular stimuli (33) . Many growth factors, acting through either G protein-coupled receptors or receptor tyrosine kinases, promote cell survival by activating one of the PI-3 kinase isoforms (44) . Our data demonstrate that the antiapoptotic effect of each phospholipid in osteoblastic cells is PI-3 kinase dependent, because in each case it was blocked by the specific PI-3 kinase inhibitors LY294002 and wortmannin. This observation is consistent with studies of survival signaling activated by LPA in renal tubular cells (45) , Schwann cells (24) , and macrophages (23) , and by S1P in hepatocytes (46) , which implicate PI-3 kinase in the pathway subserving cell survival. However, PI-3 kinase is not universally a mediator of phospholipid-induced cell survival. Our studies in Swiss 3T3 fibroblastic cells indicate that the LPA-induced antiapoptotic effects are not dependent on this enzyme. This finding is consistent with those of Fang et al. (26) , who reported that PI-3 kinase does not transduce the LPA survival signal in NIH 3T3 cells. Thus, there appears to be cell-type specificity in the mechanisms by which LPA prevents apoptosis. In addition, there is ligand specificity in phospholipid-induced fibroblast survival because the antiapoptotic effect of S1P, but not that of LPA, is PI-3 kinase dependent. The mechanism(s) underlying the cell-type and ligand specificity we observed are uncertain.
The identity of the PI-3 kinase-dependent effector(s) that mediate phospholipid-induced osteoblast survival remains uncertain. It is currently believed that the lipid products generated by activation of PI-3 kinase enable the kinase activity of 3-phosphoinositide-dependent kinases toward a number of potential downstream effectors (47) . Some data suggest that PKB/Akt is a critical component of the survival signal downstream of PI-3 kinase/phosphoinositidedependent kinase-1 (33, 48) . However, we were unable to detect activation of PKB/Akt in osteoblastic cells in response to either LPA or S1P, as assessed by immunoblotting for phosphorylation at the critical Ser 473 site. In contrast, low concentrations of FCS and IGF-1 reproducibly induced PKB/ Akt phosphorylation in the same cells (Fig. 4, and data not  shown) . Thus, we believe it unlikely that PKB/Akt plays a major role in phospholipid-induced osteoblast survival. PI-3 kinase-dependent signaling was activated by each of the phospholipids in osteoblastic cells, as evidenced by LPA-and S1P-induced phosphorylation of p70 S6 kinase on Thr 389 , which was abrogated by the specific PI-3 kinase inhibitor LY294002. Activation of the ribosomal enzyme p70 S6 kinase has been implicated as a mediator of growth factor-induced survival (36) . Although we observed activation of p70 S6 kinase in response to both LPA and S1P, specific inhibition of p70 S6 kinase activity using rapamycin did not prevent the antiapoptotic effect of either phospholipid. This finding again illustrates the occurrence of cell-type specificity in phospholipid signaling because rapamycin inhibits LPAinduced survival in macrophages (23) . Other potential PI-3 kinase-dependent mediators of survival signaling include protein kinase C isoforms (49), the recently described serumand glucocorticoid-induced kinases (50, 51) , which are structurally homologous to Akt/PKB, and protein kinase A (52) .
In summary, the current paper reports for the first time that the naturally occurring phospholipid compounds LPA and S1P potently prevent apoptosis in osteoblastic cells. This effect is likely to be mediated by a member(s) of the edg/lp family of G protein-coupled receptors because it was in each case completely inhibited by the G i protein inhibitor pertussis toxin. Activation of PI-3 kinase is also required for phospholipid-induced osteoblast survival, whereas p42/44 MAPK signaling is not. The downstream components of the PI-3 kinase-dependent survival signal activated by LPA and S1P in osteoblasts are uncertain, but neither PKB/Akt nor p70 S6 kinase appears to be involved. The intracellular pathways by which LPA and S1P prevent apoptosis in osteoblastic cells differ from those required for prevention of fibroblast apoptosis. Phospholipids may contribute to the regulation of osteoblast cell fate in vivo.
